Table 3.
Latent feature | Total (%) | Single feature (%) | Dominant feature |
---|---|---|---|
1 | 100 | 84.28 | High blood pressure |
2 | 2.30 | 1.58 | Congestive heart failure |
3 | 1.89 | 1.47 | Hypothyroidism |
4 | 1.87 | 1.34 | Irritable bowel syndrome |
5 | 1.65 | 1.28 | Obesity |
6 | 1.53 | 1.07 | Intermittent claudication |
7 | 1.34 | 1.02 | Primary open-angle glaucoma |
8 | 1.29 | 0.85 | Arthropathy |
9 | 1.24 | 0.87 | Chronic bronchitis |
10 | 1.13 | 0.84 | Psoriasis or eczema |
11 | 1.12 | 0.77 | Cervical spondylosis |
12 | 1.11 | 0.78 | Neuropathy |
13 | 1.07 | 0.70 | Angina pectoris |
14 | 1.01 | 0.72 | Chronic kidney disease |
The total column represents the total number of patients with the individual latent feature. While the single feature column represents the number of patients with at least that specific latent feature active. Each latent feature (LF) corresponds to a group of comorbidities. However, for each latent feature, one dominant comorbidity was identified (see Table 2).